Evidence map›Paper›PMID 42834095›Full record

ArticleNature communications2026

K-MARVEL: K-Mer-based antimicrobial resistance virtual exploration lab.

Nirmal Singh Mahar, Sverre Branders, Manfred G Grabherr, Ishaan Gupta, Rafi Ahmad

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nirmal Singh MaharDepartment of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi, India.ORCID 0000-0001-6296-0494
Sverre BrandersDepartment of Biotechnology, University of Inland Norway, Hamar, Norway.ORCID 0009-0007-6493-8144
Manfred G GrabherrDepartment of Biotechnology, University of Inland Norway, Hamar, Norway.
Ishaan GuptaDepartment of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi, India. ishaan@dbeb.iitd.ac.in.
Rafi AhmadDepartment of Biotechnology, University of Inland Norway, Hamar, Norway. rafi.ahmad@inn.no.ORCID 0000-0002-0383-7848

Funding

Norges Forskningsråd (Research Council of Norway) OH-AMR-Diag (project number 336420)Norges Forskningsråd (Research Council of Norway) UTI-Diag (project number 352514)
6 · The paper itself

Abstract

The rapid spread of antimicrobial resistance (AMR) necessitates new computational surveillance tools. Current methods for analysis of next-generation sequencing data have trade-offs: assembly-based approaches are computationally intensive, and direct long-read mapping is hampered by high error rates that obscure resistance-conferring mutations. Here, we present K-MARVEL, an open-source method that captures antimicrobial resistance genes (ARGs) and resistance-conferring mutations from both short- and long-read datasets. Operating in protein k-mer space, K-MARVEL tolerates nucleotide-level sequencing errors. We benchmarked K-MARVEL on 209 long-read and 205 short-read datasets across 22 bacterial species and achieved F1-scores of 0.976 (short-read) and 0.958 (long-read), outperforming assembly-based methods in speed and memory usage. K-MARVEL had higher F1-scores than seven widely used short-read-based ARG classifiers (0.979) and two widely used long-read-based classifiers (0.961) for homology-model-based ARGs. K-MARVEL can accurately identify both homologous ARGs and structural genes containing resistance-conferring mutations, including multiple variants, directly from raw sequencing data.

Indexed as

BacteriaComputational BiologyDrug Resistance, BacterialAnti-Bacterial AgentsGenes, BacterialHigh-Throughput Nucleotide SequencingMutationAnti-Bacterial Agents

Identifiers

PMID42834095
PMCPMC13639074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.